Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo
Authors:
Open Access
- 1 June 2019
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 5883-5894
Abstract
Background: Hepatic cancer is the most common primary liver malignancy, with high incidence and mortality worldwide. Atractylon is an active constituent isolated from Atractylodes lancea (Thunb.) DC. and Atractylodes chinensis (DC.) Koidz., which proved to have multiple activities. Methods: In this study, we evaluated the antihepatic cancer (HCC) effect of atractylon in vitro and in vivo and investigated its underlying mechanism. Cell proliferation, colony formation, cell apoptosis, migration and invaison and was identified by MTT, crystal violet staining, flow cytometry analysis, and Transwell assay. The ∆Ψm of HepG2 and MHCC97H cells were detected by Rhodamine 123. The ROS level was determined by 2,7-Dichlorodi-hydrofluorescein diacetate (DCFH-DA) method. Protein expression was identified by Western blot analysis. The anti-HCC effect of atractylon in vivo was evaluated by a subcutaneous tumor model. Results: The results suggested that atractylon significantly inhibits the proliferation and promotes apoptosis of hepatic cancer cell lines, including HepG2, SMCC7721, and MHCC97H. Moreover, the results showed that atractylon reduces the mitochondrial membrane potential (∆Ψm), increases ROS level, inhibits the expression of Bcl-2, and promotes the expression of Bax and cleaved caspase-3, indicating that atractylon induces HCC apoptosis through the mitochondrial apoptotic pathway. Our results also demonstrated that atractylon inhibits migration and invasion of hepatic cancer cells by inhibiting the epithelial-mesenchymal transition (EMT) process and downregulating MMP-2 and MMP-9 expression. In addition, atractylon inhibited the growth of hepatic cancer and showed an inhibition effect on EMT process in vivo. Conclusion: In all, this study suggested that atractylon showed a promising anti-HCC effect with inhibiting proliferation, inducing apoptosis, and blocking invasion in vitro and inhibiting growth in vivo.Keywords
This publication has 26 references indexed in Scilit:
- Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasionBreast Cancer Research and Treatment, 2012
- Mechanisms regulating colorectal cancer cell metastasis into liver (Review)Oncology Letters, 2011
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cellsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasisMolecular BioSystems, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosisJournal of Cell Science, 2009
- Specific inhibition of Na+, K+-ATPase activity by atractylon, a major component of Byaku-jutsu, by interaction with enzyme in the E2 stateBiochemical Pharmacology, 1996
- Atractylodis Rhizoma extract and its component, atractylon, inhibit tumor promotion in mouse skin two-stage carcinogenesisPhytomedicine, 1994
- Antihepatotoxic Principles of Atractylodes RhizomesJournal of Natural Products, 1983